Innovation, Research
EG427: treating neurogenic bladder with precision gene therapy
… pill given continuously to Sleeping Beauty,” explains Philippe Chambon, the CEO, co-founder and a shareholder of … proof of concept and file a patent. At the start of 2019, Philippe Chambon obtained a licence for the project. This … pill given continuously to Sleeping Beauty,” explains Philippe Chambon, the CEO, co-founder and a shareholder of …Published on: